Skip to content

Evaluation of Placentrex Injection for Post-Extraction Healing in Controlled Diabetic Patients: A Prospective Interventional Approach

Evaluation of Placentrex injection for Post-Extraction Healing in Controlled Diabetic Patients A Prospective Interventional Approach - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104674
Enrollment
86
Registered
2026-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Injection placentrex: the patient will be given the cap amoxicillin 1 gm before the procedure and administering injection placentrex in the buccal mucosa around the extraction socket af

Sponsors

Dr Lavanya Agarwal
Lead Sponsor
Association of Oral and Maxillofacial Surgery
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Subjects who understand the study and are willing to participate in it. Subjects falling in the age group of 20 to 70 years Subjects requiring dental extractions. Poor endodontic and periodontal prognosis, Patients with systolic blood pressure falling in range of 110-140 mmHg and diastolic blood pressure ranging between 70-100 mmHg. Patient falling in the criteria of GRBS (Glucometer Random Blood Sugar) less than or equal to 180 mg/dL and HbA1c (Glycated Hemoglobin) less than equal to 7.5%

Exclusion criteria

Exclusion criteria: Individual with known senstivity to pharmaceuticals or drugs to be used in the study. Subject with the habit of smoking and alcohol consumption. Subject with uncontrolled diabetes and any other metabolic disorders/immunocompromised. Subjects undergoing chemotherapy or radiotherapy and are on immunosuppresant therapy. Female subjects who are pregnant and lactating mothers. Female subjects taking oral contraceptives. Subjects who are not available/not willing for follow up procedure. Patient with space infection, extraoral/intraoral infection.

Design outcomes

Primary

MeasureTime frame
evaluation of the anti bacterial efficacy of the inj placentrexTimepoint: day1,3,and7

Secondary

MeasureTime frame
evaluation of the wound healing after the application of the inj placentrexTimepoint: day1,3,and7

Countries

India

Contacts

Public ContactDr Arvind R

Manipal College Of Dental Sciences Mangalore

lavanyaagarwal40@gmail.com9664013867

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026